Antimicrobial resistance is a major public health problem globally. Likewise, forms of
tuberculosis (TB) resistant to first-and second-line TB medicines present a major challenge …

The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19)
pandemic has attracted interest because of its global rapid spread, clinical severity, high …

Background Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is
still limited. The aim of this study was to describe the features of the TB/COVID-19 co …

Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in
16 countries on 5 continents showed that attendance at tuberculosis centers was lower …

Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim
of this study is to describe a group of patients who died with TB (active disease or sequelae) …

Aim The aim of this review is to inform the reader on the latest developments in
epidemiology, diagnostics and management. Epidemiology Drug-resistant Tuberculosis (DR …

Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …

BACKGROUND: Optimal drug dosing is important to ensure adequate response to
treatment, prevent development of drug resistance and reduce drug toxicity. The aim of …